DOI QR코드

DOI QR Code

차가버섯 추출물의 MMPs 발현 저해 및 HAS-2 발현 증가효과

Effect of Inonotus obliquus Extract on the Expression MMPs and HAS-2

  • 이소헌 ((주)바이오랜드 생명공학연구소) ;
  • 박선희 ((주)바이오랜드 생명공학연구소) ;
  • 이강혁 ((주)바이오랜드 생명공학연구소) ;
  • 박수진 ((주)바이오랜드 생명공학연구소) ;
  • 김영희 ((주)바이오랜드 생명공학연구소)
  • 투고 : 2011.09.05
  • 심사 : 2011.09.17
  • 발행 : 2011.09.30

초록

본 연구에서는 차가버섯 추출물의 주름개선 화장품 원료로의 가능성을 확인하기 위하여, 차가버섯의 70 % 에탄올 추출물을 제조하여, DPPH (1,1-diphenyl-2- picrylhydrazyl) radical 소거능, 엘라스타제 저해능, MMPs (matrix metalloproteinases) 발현 저해 및 HAS-2 (hyaluronan synthase-2) 발현 저해 효능을 측정하였다. 차가버섯 추출물 및 함유성분에 대한 DPPH radical 소거능과 엘라스타제 저해 효능을 측정한 결과, 차가버섯 추출물은 농도 의존적으로 DPPH radical 소거능 및 엘라스타제 저해 효능을 보였으며($SC_{50}$ = 91 ${\mu}g$/mL, $IC_{50}$ = 124 ${\mu}g$/mL), 함유성분 중 Gallic acid가 가장 우수한 결과를 나타내었다. MMPs 발현능 평가에서, 차가버섯 추출물은 5 ~ 25 ${\mu}g$/mL의 농도에서 50 ~ 79 % MMP-1 mRNA 발현을 저해하였으며 MMP-2의 발현량을 측정한 결과, 10 ${\mu}g$/mL에서 약 20 %를 감소시켰다. MMP-9의 발현에서도 5 ~ 25 ${\mu}g$/mL의 농도에서 54 ~ 70 %의 저해 효과를 나타내었다. 또한 HAS-2의 mRNA 발현량을 측정한 결과, 차가버섯 추출물이 전 농도에서 농도 의존적으로 HAS-2 발현량을 증가시켰다. 상기 결과를 종합해 볼 때 차가버섯 추출물은 주름개선 화장품 소재로서 개발이 가능할 것으로 사료된다.

In order to investigate the possibility of Inonotus obliquus extract as an active ingredient for wrinkle-care cosmetics, we prepared 70 % ethanolic extract of Inonotus obliquus and measured its DPPH radical scavenging activity and elastase inhibitory activity. We also evaluated the effect of Inonotus obliquus extract on expression of MMPs and HAS-2 in fibroblast and HaCaT cell, respectively. Inonotus Obliquus extract showed DPPH radical scavenging activity and elastase inhibitory activity in a dose-dependant manner ($SC_{50}$ = 91 ${\mu}g$/mL, $IC_{50}$=124 ${\mu}g$/mL). Inonotus obliquus extract inhibited the expression of MMP-1 mRNA 50 ~ 79 % at concentrations of 5 ~ 25 ${\mu}g$/mL, and reduced the expression of MMP-2 around 20 % at a concentration of 10 ${\mu}g$/mL. And it also reduced the expression of MMP-9 54 ~ 70 % in tconcentrations of 5 to 25 ${\mu}g$/mL. Furthermore, Inonotus obliquus extract increased HAS-2 mRNA expression in a dose-dependent manner in concentrations of 5 to 25 ${\mu}g$/mL without cytotoxicity. These results suggested that Inonotus Obliquus extract could be useful as an active ingredient for wrinkle-care cosmetics.

키워드

참고문헌

  1. J. H. Chung, Photoaging in asians, Photodermatol. Phtoimmunnol photomed., 19, 109 (2003). https://doi.org/10.1034/j.1600-0781.2003.00027.x
  2. K. Takeda, S. Harada, and M. Ando, Funtional cosmetology, society of cosmetic chemists of japan, Yakuji Nippo Ltd., 1, 163 (2004).
  3. K. Fraizer, S. Williams, D. Kothapal, H. Klapper, and G. R. Grotendorst, Stimulation of fibroblast cell-growth, matrix production, and granulationtissue formation by connective-tissue growth-factor, Journal of Investigative Dermatology, 107(3), 404 (1996). https://doi.org/10.1111/1523-1747.ep12363389
  4. P. Brenneisen, and J. S. Oh, et al., Ultraviolet B wavelength dependence for the regulation of two major matrix-metalloproteinases and their inhibitor TIMP-1 in human dermal fibroblasts, Photochemistry & Photobiology, 64(5), 877 (1996). https://doi.org/10.1111/j.1751-1097.1996.tb01851.x
  5. M. O. Longas, C. S. Russell, and X. Y. He, Evidence for structural changes in dermatan sulfate and hyaluronic acid with aging, Carbohydr. Res., 159, 127 (1987). https://doi.org/10.1016/S0008-6215(00)90010-7
  6. I. Gheretich, T. Lotti, G. Campanile, C. Grappone, and G. Dini, Hyaluronic acid in custaneous intrinsic aging, Int. J. Dermatol., 33, 119 (1994). https://doi.org/10.1111/j.1365-4362.1994.tb01540.x
  7. L. Kier, Tritepenes of Poria obliqua, J. Pharm. Sci., 50(6), 471 (1961). https://doi.org/10.1002/jps.2600500605
  8. A. N. Shibirina, Chemical characteristics of compounds extracted from Inonotus obliquus, Chem. Abstr., 66, 17271 (1967).
  9. K. Kahlos and R. Hiltunen, Identification of some lanostane type triperpenes from Inonotus obliquus, Acta Pharm Fenn., 92, 220 (1983).
  10. H. J. Kim, C. B. Jin, and Y. S. Lee, Antioxidative activities of phenolic compounds isolated from Inonotus obliquus, Kor. J. Pharmacogn., 38(2), 164 (2007).
  11. K. C. Park, H. S. Han, and Y. J. Lee, The Comparative study of the effects of Fructificatio Inonoti obliqui aqueous extract according to the extraction temperature(2)-anti-oxidative activity, anti inflammatory effect and cancer cell multiplication inhibition effect, Kor. J. Herbology, 22(4), 187 (2007).
  12. T. Mizuno, C. Zhuang, K. Abe, H. Okamoto, T. Kiho, S. Ukai, S. Leelere, and Meijer, Antitumor and hypoglycemic activities of polysaccharides from the sclerotia and mycelia of Inonotus obliquus (Per:FR.) Pil. (Aplryllophoromycetidae), Int. J. Med. Mushrooms, 1, 301 (1999). https://doi.org/10.1615/IntJMedMushr.v1.i4.20
  13. Y. S. Shin, Y. Tamai, and M. Terazawa, Citation chemical constituents of Inonotus obliquus I.:A new triterpene, 3$\beta$-hydroxy-8,24-dien-lanosta-21,23- lactone from sclerotium, Eurasian Journal of Forest Research, 1, 43 (2000).
  14. S. P. Wasser and A. L. Weis, Therapeutic effects of substances occurring in higher Basidiomycetes mushrooms: a modern perspective, Crit. Rev. Immunol., 19(1), 65 (1999).
  15. K. Kahlos and V. H. Tikka, Antifungal activity of cysteine, Its effect on C-21 oxygenated lanosterol derivatives and other lipids in Inonotus-obliquus, in-vitro, Applied Microbiology and Biotechnology, 42(2-3), 385 (1994).
  16. T. Ichimura, T. Otake, H. Mori, and S. Maruyama, HIV-1 protease inhibition and anti-HIV effect of natural and synthetic water-soluble lignin-like substances, Biosci. Biotechnol. Biochem., 63(12), 2202 (1999). https://doi.org/10.1271/bbb.63.2202
  17. K. Kahlos, L. Kangas, and R. Hiltunen, Antitumor activity of some compounds and fractions from an n-hexane extract of Inonotus obliquus in vitro, Acta Pharm Fennica, 96, 33 (1987).
  18. Y. O. Kim, H. W. Park, J. H. Kim, J. Y. Lee, S. H. Moon, and C. S. Shin, Anti-cancer effect and structural characterization of endo-polysaccharide from cultivated mycelia of Inonotus obliquus, Life Sci., 79(1), 72 (2006). https://doi.org/10.1016/j.lfs.2005.12.047
  19. J. S. Choi, Screening on radical savenging activity of marine microalgae, Kor. J. Pharmacogn, 21(2), 252 (2000).
  20. A. A. Van de Loosdrecht, E. Nennie, G. J. Ossenkoppele, R. H. Beelen, and M. M. Langenhuijsen, Cell mediated cytotoxicity against U 937 cells by human monocytes and macrophages in a modified colorimetric MTT assay. A methodological study, J. Immunol. Methods, 141(1), 15 (1991). https://doi.org/10.1016/0022-1759(91)90205-T
  21. H. K. Ju, H. W. Chung, S. S. Hong, J. H. Park a, J. M. Lee, and S. W. Kwon, Effect of steam treatment on soluble phenolic content and antioxidant activity of the Chaga mushroom (Inonotus obliquus), Food Chemistry, 119(2), 619 (2010). https://doi.org/10.1016/j.foodchem.2009.07.006